GILBERTO DE CASTRO JUNIOR
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/24 - Laboratório de Oncologia Experimental, Hospital das Clínicas, Faculdade de Medicina - Líder
LIM/24 - Laboratório de Oncologia Experimental, Hospital das Clínicas, Faculdade de Medicina - Líder
7 resultados
Resultados de Busca
Agora exibindo 1 - 7 de 7
- MicroRNA expression in saliva in locally advanced oral and oropharyngeal squamous cell carcinoma(2015) GARCIA, Fabyane Oliveira Teixeira; CONSTANTINO, Vivian Marinelli; MAK, Milena Perez; CASTRO- JR., Gilberto de; PASINI, Fatima S.
conferenceObject KeyVibe-003: Randomized, double-blind, phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1-positive metastatic NSCLC(2022) CHO, Byoung Chul; JUERGENS, Rosalyn A.; CHENG, Ying; CASTRO JR., Gilberto de; ERMAN, Mustafa; BAUMAN, Jessica R.; TAKAHASHI, Toshiaki; SCHWARZENBERGER, Paul; LI, Chengxiang; PIETANZA, M. Catherine; YANG, James Chih-Hsin- Real-world clinical characteristics and treatment (tx) outcomes by co-mutation status in patients (pts) with KRAS G12C- mutated non-small cell lung cancer (NSCLC)(2023) NEGRAO, Marcelo V.; WU, Wen-Hsing; LINDSAY, Colin R.; CAPARICA, Rafael; PRETRE, Vincent; KANG, Yehrim; CARO, Nydia; FARAGO, Anna; YE, Fen; CASTRO JR., Gilberto de
- Relationship between STK11 and KEAP1 mutational status and efficacy in KEYNOTE-042: pembrolizumab monotherapy versus platinum-based chemotherapy as first-line therapy for PD-L1-positive advanced NSCLC(2020) CHO, Byoung Chul; LOPES, Gilberto; KOWALSKI, Dariusz M.; KASAHARA, Kazuo; WU, Yi-Long; CASTRO, Gilberto; TURNA, Hande Z.; CRISTESCU, Razvan; AURORA-GARG, Deepti; LOBODA, Andrey; LUNCEFORD, Jared; KOBIE, Julie; AYERS, Mark; PIETANZA, M. Catherine; PIPERDI, Bilal; MOK, Tony S.
- A Phase II trial of JDQ443 in KRAS G12C-mutated NSCLC with PD-L1 expression <1% or PD-L1 expression≥1% and an STK11 co-mutation(2023) LINDSAY, Colin R.; TAN, Daniel; MALHOTRA, Shweta; CAPARICA, Rafael; BORAN, Aislyn D.; CASTRO, Gilberto; GLASER, Sabine; VELUSWAMY, Rajwanth R.; FELIP, Enriqueta
conferenceObject Canakinumab in combination with first-line (1L) pembrolizumab plus chemotherapy for advanced non-small cell lung cancer (aNSCLC): Results from the CANOPY-1 phase 3 trial.(2022) TAN, Daniel S.; FELIP, Enriqueta; CASTRO, Gilberto; SOLOMON, Benjamin J.; GREYSTOKE, Alastair; CHO, Byoungchul; COBO, Manuel; KIM, Tae Min; GANGULY, Sandip; CARCERENY, Enric; PAZ-ARES, Luis; BENNOUNA, Jaafar; GARASSINO, Marina; SCHENKER, Michael; KIM, Sang-We; MOOKERJE, Bijoyesh; PASSOS, Vanessa Q.; DEUDON, Stephanie; DHARAN, Bharani; SONG, Yuanbo; CAPARICA, Rafael; JOHNSON, Bruce E.- Efficacy of first-line (1L) pembrolizumab by PD-L1 combined positive score < 1, 1-19, and >= 20 in recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): KEYNOTE-048 subgroup analysis(2020) BURTNESS, Barbara; RISCHIN, Danny; GREIL, Richard; SOULIERES, Denis; TAHARA, Makoto; CASTRO, Gilberto de; PSYRRI, Amanda; BASTE, Neus; NEUPANE, Prakash; BRATLAND, Ase; FUEREDER, Thorsten; HUGHES, Brett G.; MESIA, Ricard; NGAMPHAIBOON, Nuttapong; RORDORF, Tamara; ISHAK, Wan Zamaniah Wan; GE, Joy; SWABY, Ramona; GUMUSCU, Burak; HARRINGTON, Kevin